These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 37006441)

  • 1. Safety and Effectiveness of SA58 Nasal Spray Against COVID-19 Infection in Medical Personnel: An Open-Label, Blank-Controlled Study - Hohhot City, Inner Mongolia Autonomous Region, China, 2022.
    Si S; Jin C; Li J; Cao Y; Kan B; Xue F; Xie XS; Fang L; Zeng G; Zhang S; Hu Y; Dong X
    China CDC Wkly; 2023 Mar; 5(10):218-222. PubMed ID: 37006441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
    Lin Y; Yue S; Yang Y; Yang S; Pan Z; Yang X; Gao L; Zhou J; Li Z; Hu L; Tang J; Wu Q; Lei S; Tian Q; Wang Y; Hao Y; Xu L; Huang Q; Zhu B; Chen Y; Chen X; Ye L
    Clin Infect Dis; 2023 Feb; 76(3):e336-e341. PubMed ID: 35666466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial.
    Cegolon L; Mastrangelo G; Emanuelli E; Camerotto R; Spinato G; Frezza D
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432693
    [No Abstract]   [Full Text] [Related]  

  • 4. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area.
    Meng Z; Wang T; Chen L; Chen X; Li L; Qin X; Li H; Luo J
    Curr Top Med Chem; 2021; 21(10):920-927. PubMed ID: 33970846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents.
    Cao Y; Jian F; Zhang Z; Yisimayi A; Hao X; Bao L; Yuan F; Yu Y; Du S; Wang J; Xiao T; Song W; Zhang Y; Liu P; An R; Wang P; Wang Y; Yang S; Niu X; Zhang Y; Gu Q; Shao F; Hu Y; Yin W; Zheng A; Wang Y; Qin C; Jin R; Xiao J; Xie XS
    Cell Rep; 2022 Dec; 41(12):111845. PubMed ID: 36493787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, China.
    Ma C; Huang C; Wang W; Song Y; Jiang X; Tian X; Liu B; Chi F; Lang S; Liu D; Sun W; Tang L; Wu D; Song Y; Li J; Rodewald L; Yin Z; An Z
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
    Lam JY; Ng YY; Yuen CK; Wong WM; Yuen KY; Kok KH
    Emerg Microbes Infect; 2022 Dec; 11(1):964-967. PubMed ID: 35275039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Plague Case Diagnosed in Ningxia Tracked to Animal Reservoirs - Inner Mongolia Autonomous Region, China, 2021.
    Gao J; Hu Y; Ju C; Liu J; Wang Y; Ma J; Shen X; Liu F; Guo J; Yu X; Zhang W; Wang S; Li K; Zhang Z; Kan B; Wang W; Cong X; Fan M; Li W; Shao K; Zhang T; Li J; Wang Y
    China CDC Wkly; 2021 Dec; 3(52):1109-1112. PubMed ID: 35186366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Seo JM; Kang B; Song R; Noh H; Kim C; Kim JI; Kim M; Ryu DK; Lee MH; Yang JS; Kim KC; Lee JY; Lee H; Woo HM; Kim JW; Choi JA; Song M; Tomaszewska-Kiecana M; Wołowik A; Kulesza A; Kim S; Ahn K; Jung N; Lee SY
    Emerg Microbes Infect; 2022 Dec; 11(1):2315-2325. PubMed ID: 36006772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
    Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
    Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.
    Xu N; Pan J; Sun L; Zhou C; Huang S; Chen M; Zhang J; Zhu T; Li J; Zhang H; Gao Y
    Front Immunol; 2022; 13():967716. PubMed ID: 35990674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Intervention System: COVID-19 Control in Inner Mongolia Autonomous Region, China.
    Zou Y; Wang Q; Deng M; Wang Y
    Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristic and evaluation of soil pollution by heavy metal in different functional zones of Hohhot].
    Guo W; Sun WH; Zhao RX; Zhao WJ; Fu RY; Zhang J
    Huan Jing Ke Xue; 2013 Apr; 34(4):1561-7. PubMed ID: 23798143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
    Segal EB; Tarquinio D; Miller I; Wheless JW; Dlugos D; Biton V; Cascino GD; Desai J; Hogan RE; Liow K; Sperling MR; Vazquez B; Cook DF; Rabinowicz AL; Carrazana E;
    Epilepsia; 2021 Jun; 62(6):1442-1450. PubMed ID: 33942315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series.
    Go CC; Pandav K; Sanchez-Gonzalez MA; Ferrer G
    Cureus; 2020 Nov; 12(11):e11315. PubMed ID: 33173650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 - Jilin City, Jilin Province, China, March 3-April 12, 2022.
    Fan X; Lu S; Bai L; Liu H; Fu J; Jin X; He Y; Lu J; Dong X
    China CDC Wkly; 2022 May; 4(18):377-380. PubMed ID: 35686205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.